|
2025
|
Invention
|
Prmt5 inhibitors for use in methods of treating mta-accumulating cancer. Provided herein are diag... |
|
|
Invention
|
Crystalline forms of hdac inhibitor and uses thereof. The disclosure relates to crystalline forms... |
|
|
Invention
|
Crystalline forms, pharmaceutical compositions and methods of use thereof. Pharmaceutical composi... |
|
2024
|
Invention
|
Hdac inhibitors and therapeutic use thereof.
Described herein are novel compounds, compositions ... |
|
|
Invention
|
Compounds and their use against cancer. Compounds are provided according to Formula (I) and Formu... |
|
|
Invention
|
Compounds and their use against cancer. Compounds are provided according to Formula (I) or Formul... |
|
|
Invention
|
N2-((5-hydroxy)-2-pyridyl)-pyridine-2,4-diamine derivatives as ehmt1/2 modulators for the treatme... |
|
|
Invention
|
Compounds and methods of use. Compounds are provided according to Formula (I):
8 and n are as de... |
|
2023
|
Invention
|
Crystalline forms, pharmaceutical compositions and methods of use thereof.
Crystalline forms and... |
|
|
Invention
|
Crystalline forms, pharmaceutical compositions and methods of use thereof. Crystalline forms and ... |
|
|
Invention
|
An hdac inhibitor for treating cancer with a modified stk11 activity or expression. The disclosur... |
|
|
P/S
|
Pharmaceutical and therapeutic preparations for the treatment of cancer. Pharmaceutical research ... |
|
|
P/S
|
Pharmaceutical and therapeutic preparations for the treatment of cancer. Research and development... |
|
|
Invention
|
Compounds and methods of use.
Provided are compounds of Formula (I): (I), and pharmaceutically a... |
|
|
Invention
|
Compounds and methods of use.
Provided are compounds of Formula (A) and Formula (I): (I), and ph... |
|
|
Invention
|
Compounds and methods of use.
Provided are compounds of Formula (A): Formula (A); and pharmaceut... |
|
|
Invention
|
Compounds and methods of use. Provided are compounds of Formula (I): (I), and pharmaceutically ac... |
|
|
Invention
|
Compounds and methods of use. Provided are compounds of Formula (A): Formula (A); and pharmaceuti... |
|
|
Invention
|
Compounds and methods of use. Provided are compounds of Formula (A) and Formula (I): (I), and pha... |
|
2022
|
Invention
|
Crystalline form of n-(6-amino-5-methylpyridin-3-yl)-2-(benzo[d]thiazol-5-yl)-5-methylpiperidin-1... |
|
|
Invention
|
Hdac inhibitors and therapeutic use thereof. Described herein are novel compounds, compositions a... |
|
|
Invention
|
Novel hdac inhibitors and therapeutic use thereof. Described herein are novel compounds, composit... |
|
|
Invention
|
Novel modulators of ehmt1 and ehmt2 and therapeutic use thereof.
Described herein are novel comp... |
|
|
Invention
|
Novel modulators of ehmt1 and ehmt2 and therapeutic use thereof. Described herein are novel compo... |
|
|
P/S
|
pharmaceutical and therapeutic preparations for the treatment of cancer research and development ... |
|
|
Invention
|
Purine derivatives as anticancer agents. Compounds are provided according to Formula (I). Formula... |
|
|
Invention
|
Pyrrolo[3,2-d]pyrimidine compounds and methods of use in the treatment of cancer.
Compounds are ... |
|
|
Invention
|
Pyrrolo[3,2-d]pyrimidine compounds and methods of use in the treatment of cancer. Compounds are p... |
|
2021
|
Invention
|
Piperidin-1- yl-n-pyrydi ne-3-yl-2-oxoacet am ide derivatives useful for the treatment of mtap-de... |
|
|
Invention
|
Compounds and methods of use. Compounds are provided according to Formula (I):
5, m and n are as... |
|
|
P/S
|
Pharmaceutical and therapeutic preparations for the treatment of cancer Research and development ... |
|
2020
|
Invention
|
Compounds and methods of use. 5, m and n are as defined herein. Compounds of the present inventio... |
|
|
Invention
|
Compounds and methods of use. Compounds are provided according to Formula (I): and pharmaceutical... |
